Search - tctmd.com

Displaying 161 - 180 of 181

Sort: Relevancy | Date

News Industry News

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

February 26, 2019

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Industry News

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

February 04, 2019

News Industry News

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

January 22, 2019

News Daily News

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

L.A. McKeown

January 21, 2019

News Opinion Fellow Talk

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Luai Tabaza, MD

January 10, 2019

News Features

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Shelley Wood

January 01, 2019

Manuscript

Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment

May 31, 2017

Partner Content

TAVR Program Administration & Logistics - Medtronic

November 1, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Suzanne Baron About the Cost-Effectiveness Analysis from COAPT and Health Status Outcomes from PARTNER 3

September 29, 2019

Video

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

September 28, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Raj Makkar About the PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

September 26, 2019

EVENT

CACI in Partnership With TCT

November 29, 2019

December 01, 2019

CME

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

Video

» Interview

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

March 18, 2019

CME

Advertisement

Robocath obtains CE marking for R-One™, its robotic-assisted solution for treating coronary diseases

Breast Calcifications May Hold Important Clues for CV Risk Stratification

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

First Atrial Fibrillation Patient Treated In Biosense Webster U.S. IDE Study Evaluating High Power, Short Duration Ablation Catheter

Robocath’s R-One™ robot acquired by the Medical Training & Testing Center in Rouen for future healthcare practitioner training

Device Embolization: Tools and Training Essential to Avoid Worst-Case Scenarios

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Rover’s Regurgitation: Veterinarian-Cardiologist Teamwork Could Speed Device Innovation, Training

Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment

TAVR Program Administration & Logistics - Medtronic

Dr. C. Michael Gibson Talks With Dr. Suzanne Baron About the Cost-Effectiveness Analysis from COAPT and Health Status Outcomes from PARTNER 3

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

Dr. C. Michael Gibson Talks With Dr. Vinod Thourani About PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis

Dr. C. Michael Gibson Talks With Dr. Raj Makkar About the PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

CACI in Partnership With TCT

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low Risk Patients with Aortic Stenosis

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

New Clinical Data on TAVR use and Intermediate Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content